Oral preparation series
Product Description
Jiangsu Yingke Biological Pharmaceutical Co., Ltd
-
Country/Region:China
-
On CPHI since:2025
Jiangsu Yingke Biological Pharmaceutical Co., Ltd
-
Country/Region:China
-
On CPHI since:2025
More Products from Jiangsu Yingke Biological Pharmaceutical Co., Ltd (4)
-
Product Propofol Injectable Emulsion
Generic Drug Consistency Evaluation National Medical Insurance Class A National Essential Medicine 20 mL:0.2 g National approval number H20223914 -
Product Propofol Medium and Long Chain Lipid Injectable Emulsion
[Strength]20 mL:0.2 g Approval Number: National approval number H20203504 The first to Pass National Consistency Evaluation -
Product Three-Chamber Bag Series
1. 1440 mL Amino acids (17), Glucose (11%) and Lipid Injectable Emulsion 2. 1026 mL Amino acids (17), Glucose (19%) and Lipid Injectable Emulsion 3. 1000 mL Amino acids (15), Glucose (20%) and Lipid Injectable Emulsion (10%) 4. 1206 mL Amino acids (16), Glucose (13%) and Structural Lipid Injectabl... -
Product Topical preparation series
1. Lidocaine and Prilocaine Cream 2. Amorolfine Hydrochloride Cream 3. Mupirocin Ointment 4. Amorolfine Hydrochloride Liniment 5. Fusidic Acid Cream 6. Pimecrolimus Cream 7. Lidocaine and Tetracaine Cream


